ArticleJMIR AI2024
Obtaining the Most Accurate, Explainable Model for Predicting Chronic Obstructive Pulmonary Disease: Triangulation of Multiple Linear Regression and Machine Learning Methods.
Article in JMIR AI, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLung disease is a severe problem in the United States. Despite the decreasing rates of cigarette smoking, chronic obstructive pulmonary disease (COPD) continues to be a health burden in the United States. In this paper, we focus on COPD in the United States from 2016 to 2019.
objectiveWe gathered a diverse set of non-personally identifiable information from public data sources to better understand and predict COPD rates at the core-based statistical area (CBSA) level in the United States. Our objective was to compare linear models with machine learning models to obtain the most accurate and interpretable model of COPD.
methodsWe integrated non-personally identifiable information from multiple Centers for Disease Control and Prevention sources and used them to analyze COPD with different types of methods. We included cigarette smoking, a well-known contributing factor, and race/ethnicity because health disparities among different races and ethnicities in the United States are also well known. The models also included the air quality index, education, employment, and economic variables. We fitted models with both multiple linear regression and machine learning methods.
resultsThe most accurate multiple linear regression model has variance explained of 81.1%, mean absolute error of 0.591, and symmetric mean absolute percentage error of 9.666. The most accurate machine learning model has variance explained of 85.7%, mean absolute error of 0.456, and symmetric mean absolute percentage error of 6.956. Overall, cigarette smoking and household income are the strongest predictor variables. Moderately strong predictors include education level and unemployment level, as well as American Indian or Alaska Native, Black, and Hispanic population percentages, all measured at the CBSA level.
conclusionsThis research highlights the importance of using diverse data sources as well as multiple methods to understand and predict COPD. The most accurate model was a gradient boosted tree, which captured nonlinearities in a model whose accuracy is superior to the best multiple linear regression. Our interpretable models suggest ways that individual predictor variables can be used in tailored interventions aimed at decreasing COPD rates in specific demographic and ethnographic communities. Gaps in understanding the health impacts of poor air quality, particularly in relation to climate change, suggest a need for further research to design interventions and improve public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.